Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

CytRx begins research project with potential treatment for spinal cord injury

Feb. 19, 2001

Idun presents inhibitors of ICE/ced-3 cysteine proteases

Feb. 19, 2001

Neuroprotective Ca2+ channel blocker acts by attenuating ischemia-induced glutamate release

Feb. 19, 2001

Potential of PPARgamma agonists in stroke demonstrated in rats using troglitazone

Feb. 19, 2001

Adjunctive therapy with rufinamide safe, effective and devoid of significant PK interactions

Feb. 19, 2001

Neurocrine reports additional positive clinical results with NBI-34060 for insomnia

Feb. 19, 2001

FDA advisory committee recommends approval of injectable ziprasidone

Feb. 16, 2001

Teva finalizes separate agreements with Aventis and Lundbeck

Feb. 16, 2001

Antagonists at 5-HT2B/5-HT2C receptors designed at ADIR

Feb. 16, 2001

Triazole and imidazole derivatives from Roche are NMDA subtype-selective blockers

Feb. 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...